Breaking News Bar

Business News and Information

Here's how much top biotechs spent on R&D last quarter

Some of Massachusetts' largest biotechs spent a substantial portion of their first-quarter expenses on R&D — upwards of 75 percent among commercial companies and 87 percent among clinical-stage companies, according to data compiled by the Business Journal.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear